Two. Inosine citicoline sodium for injection not only has the function of citicoline sodium, but also has neuroprotective agent, neurotrophic agent and nerve regeneration agent for improving eyesight and protecting liver. It is mainly used to treat nerve injury, and it is also the only drug approved for the treatment of optic atrophy in China at present. At present, there are basically no similar and similar substitutes.
Three. Compound anisodine can accelerate the recovery of the normal level of vasoactive substances in the ischemic area of the eye, relieve vasospasm, maintain the normal tension and contraction function of choroidal blood vessels, increase blood flow, improve blood supply and promote the rapid recovery of ischemic tissues.
Four. Rat nerve growth factor neuroprotective agent, neurotrophic agent and nerve regeneration agent are mainly used to treat nerve injury.
2. There are dozens of manufacturers of citicoline sodium at present. If one manufacturer fails, other manufacturers can replace it immediately. Comparatively speaking, the market is chaotic. One of the main components of citicoline sodium inosine for injection is citicoline sodium and inosine. Compared with the research and development experiment, the clinical cost is high, but the effect is indeed.
3. citicoline inosine sodium for injection belongs to the function of compound preparation, and its effect is better than that of single dose;
4. citicoline inosine sodium for injection is the only drug approved by retrobulbar injection in China. Treating optic atrophy is direct and effective.
5. The national patent of citicoline sodium for drug injection, patent number: 95 1044826, patent certificate number: 37805.